Persistent idiopathic facial pain, a challenging diagnostic entity: clinical series from a third-level headache center
Background: Persistent idiopathic facial pain (PIFP) is a rare and disabling disease, often misdiagnosed. In this paper, we describe clinical phenotypes and histories of our patients with PIFP. Methods: Clinical information about pain, treatment histories, previous diagnoses, and MRI findings were assessed during the visit and collected retrospectively. Results: We observed a total of 44 females and 19 males, with a median age of 63 years. The patients had previously received diagnoses of trigeminal neuralgia, short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT), and migraine, and some had a diagnosis of PIFP. The quality of pain was described mostly as continuous, stabbing, or burning. The distribution of the pain was referred to as the trigeminal territory, mostly with a second-third branch distribution. Eighteen patients underwent dentistry procedures before the pain started. Pregabalin and carbamazepine were the most frequently prescribed treatment. In 18 patients, a neurovascular conflict was found, and all underwent invasive procedures with poor outcomes. Conclusions: PIFP is a challenging orofacial pain entity, often misdiagnosed. Knowledge of the disease is the first step toward better management. A methodological and systemic approach like that applied to neuropathic pain would be suitable. We suggest a multidisciplinary approach, including medications combined with non-pharmacological options.
Authors
- Alberto Raggi (ORCID: https://orcid.org/0000-0002-7433-7779)
- Licia Grazzi (ORCID: https://orcid.org/0000-0001-6535-1109)
- Danilo Antonio Montisano (ORCID: https://orcid.org/0000-0003-4834-2045)
- Marina de Tommaso
Institutions
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
Publication Details
- Journal
- Confinia cephalalgica.
- Published
- 2025-01-10
- DOI
- https://doi.org/10.4081/cc.2024.15773
- Primary Topic
- Trigeminal Neuralgia and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00